(MENAFN- GetNews)
"The major players in the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand)"In the near future, the respiratory care devices industry is poised for remarkable growth and innovation. Fueled by advances in technology and an increasing awareness of respiratory health, this sector is set to witness a surge in demand for state-of-the-art devices and therapies.
Respiratory Care Devices Market
in terms of revenue was estimated to be worth
$21.8 billion
in 2023 and is poised to reach
$31.8 billion
by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets. Growth in this market can primarily be attributed to the Focus on improving patient outcomes and rising R&D investments resulting in technologically advanced devices. Respiratory therapists use several approaches to improve patients' respiratory health and overall outcome. For instance, incentive spirometry is an exercise to assist patients by taking long and deep breaths to gauge how well the lungs expand. Since it needs deep breaths, it will enhance the patient's ability to clear mucus from the lungs. Such activities are taught by therapists to patients, which propels the demand for respiratory care devices.
Download an Illustrative overview:
The pulse oximeters segment holds the major share of the respiratory care monitoring devices market.
Based on product, the respiratory care monitoring devices market is segmented into pulse oximeters, capnographs and gas analyzers. The pulse oximeters segment accounted for the largest share of the respiratory care monitoring devices market in 2022. A large share of the pulse oximeters segment can be attributed to the development of innovative products, such as fingertip pulse oximeters & Bluetooth-enabled pulse oximeters, and their growing uptake.
The hospitals segment holds the major share of the respiratory care devices market.
Based on end user, the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), other end users. The hospitals segment holds the major share of the respiratory care devices market. Growing public-private partnerships to improve access to healthcare services-along with rapid developments in healthcare infrastructure and improving access to healthcare services-are expected to be the key factors driving the growth of the respiratory care devices market for hospitals in emerging economies in the coming years.
North America
segment accounted for the largest share of the respiratory care devices market.
The global respiratory care devices market is segmented into
North America,
Europe, the
Asia Pacific,
Latin America, and the
Middle East
&
Africa. In 2022,
North America
dominated the respiratory care devices market in 2022. The presence of advanced healthcare infrastructure and high healthcare expenditure in the
North America
are factors expected to drive the growth of the respiratory care devices market in the country. The high prevalence of asthma is expected to drive the demand for respiratory care devices in the US during the forecast period.
Request Sample Pages:
Respiratory Care Devices Market
Dynamics:
Drivers:
Rising prevalence of respiratory diseasesa.
Rapid growth in global geriatric populationb.
Urbanization and growing pollution levelsc.
High prevalence of tobacco smokingd.
Changing lifestyles
Increasing incidence rate of
preterm
births
Growing outbreaks of infectious diseases affecting respiratory system
Growing population with sleep disorders
Improved patient outcomes using respiratory care devices
Rising r&d investments for technological advancement of medical devices
Restraints:
Unfavorable reimbursement scenario for respiratory care diagnostics
Availability of low-cost products from local manufacturers
High cost of
cpap machines
Opportunities:
Growing demand for home care therapeutic devices
High respiratory care market growth opportunities in
asia pacific and latin america
Improving
poc diagnostics
Growing awareness about ill effects of untreated sleep apnea
Challenge:
Low awareness and lack of diagnosis of respiratory diseases
Harmful effects of certain respiratory care devices on neonates
Lack of patient compliance with
cpap therapy
Industry trends:
Rising demand for enhanced compact and portable devices
Key focus of market players on geographical expansions
Growing demand for
multimodal ventilation
Rising adoption of non-invasive ventilation
Key Market Players:
The major players in the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Drägerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan).
Get 10% Free Customization on this Report:
MENAFN05032024003238003268ID1107939823
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.